Australia's Vitura Health jumps on first supply of therapeutic 'magic' mushrooms

Vitura Health

18/03/2024 03:42

** Shares of Vitura Health  VIT.AX  jumps 6.9% to A$0.155,
their highest since Feb. 29
    ** Stock posts its biggest intraday percentage gain since
March 11
    ** Digital health co says its joint venture, Cortexa, has
supplied GMP Psilocybin for therapeutic use by a patient outside
of a clinical trial under the authorised prescriber scheme
    ** Psilocybin, more commonly known as magic mushrooms, are
used for their hallucinogenic effects
    ** Stock down ~43% YTD, as of last close

 (Reporting by Neha Soni in Bengaluru)
 ((Neha.Soni@thomsonreuters.com))